80 FR 216 pgs. 69226-69227 - A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period
Type: NOTICEVolume: 80Number: 216Pages: 69226 - 69227
Pages: 69226, 69227Docket number: [Docket Number CDC-2015-0075; NIOSH-288]
FR document: [FR Doc. 2015-28456 Filed 11-6-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2015-0075; NIOSH-288]
A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period
AGENCY:
National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice and extension of comment period.
SUMMARY:
[top] On September 8, 2015, the Director of the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register [80 FR 53802] announcing the availability of the following draft document for public comment entitled A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs. Written comments
DATES:
NIOSH is extending the comment period on the document published September 8, 2015 (80 FR 53802). Electronic or written comments must be received by March 8, 2016.
ADDRESSES:
You may submit comments, identified by CDC-2015-0075 and docket number NIOSH-288, by any of the following methods:
• Federal eRulemaking Portal: www.regulations.gov -Follow the instructions for submitting comments.
• Mail : National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998.
FOR FURTHER INFORMATION CONTACT:
Deborah V. Hirst, NIOSH, Division of Applied Research and Technology, Alice Hamilton Laboratories, 1090 Tusculum Avenue, MS R-5, Cincinnati, Ohio 45226, telephone (513) 841-4141 (not a toll free number), Email: hazardousdrugs@cdc.gov.
Dated: November 2, 2015.
John Howard,
Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2015-28456 Filed 11-6-15; 8:45 am]
BILLING CODE 4163-19-P